These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24308762)

  • 21. The Anti-Tumor Activity of Succinyl Macrolactin A Is Mediated through the β-Catenin Destruction Complex via the Suppression of Tankyrase and PI3K/Akt.
    Regmi SC; Park SY; Kim SJ; Banskota S; Shah S; Kim DH; Kim JA
    PLoS One; 2015; 10(11):e0141753. PubMed ID: 26544726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.
    Kunnimalaiyaan S; Schwartz VK; Jackson IA; Clark Gamblin T; Kunnimalaiyaan M
    BMC Cancer; 2018 May; 18(1):560. PubMed ID: 29751783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tankyrase Regulates Neurite Outgrowth through Poly(ADP-ribosyl)ation-Dependent Activation of β-Catenin Signaling.
    Mashimo M; Kita M; Uno A; Nii M; Ishihara M; Honda T; Gotoh-Kinoshita Y; Nomura A; Nakamura H; Murayama T; Kizu R; Fujii T
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tankyrase inhibition aggravates kidney injury in the absence of CD2AP.
    Kuusela S; Wang H; Wasik AA; Suleiman H; Lehtonen S
    Cell Death Dis; 2016 Jul; 7(7):e2302. PubMed ID: 27441654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury.
    Wang C; Zhu H; Sun Z; Xiang Z; Ge Y; Ni C; Luo Z; Qian W; Han X
    Am J Physiol Cell Physiol; 2014 Aug; 307(3):C234-44. PubMed ID: 24898581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human Cells.
    Kulak O; Chen H; Holohan B; Wu X; He H; Borek D; Otwinowski Z; Yamaguchi K; Garofalo LA; Ma Z; Wright W; Chen C; Shay JW; Zhang X; Lum L
    Mol Cell Biol; 2015 Jul; 35(14):2425-35. PubMed ID: 25939383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.
    Shetti D; Zhang B; Fan C; Mo C; Lee BH; Wei K
    Cells; 2019 Aug; 8(8):. PubMed ID: 31416135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tankyrases maintain homeostasis of intestinal epithelium by preventing cell death.
    Ye P; Chiang YJ; Qi Z; Li Y; Wang S; Liu Y; Li X; Chen YG
    PLoS Genet; 2018 Sep; 14(9):e1007697. PubMed ID: 30260955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XAV939-mediated ARTD activity inhibition in human MB cell lines.
    Renna C; Salaroli R; Cocchi C; Cenacchi G
    PLoS One; 2015; 10(4):e0124149. PubMed ID: 25835728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMQ-T-F5 (1-(4-(2-aminoquinazolin-7-yl)phenyl)-3-(2‑bromo‑5- (trifluoromethoxy)phenyl) thiourea) suppress proliferation and migration of human cervical HeLa cells via inhibiting Wnt/β-catenin signaling pathway.
    Dai B; Yang T; Shi X; Ma N; Kang Y; Zhang J; Zhang Y
    Phytomedicine; 2018 Dec; 51():48-57. PubMed ID: 30466627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ubiquitin conjugating enzyme E2 M promotes apoptosis in osteoarthritis chondrocytes via Wnt/β-catenin signaling.
    Ba C; Ni X; Yu J; Zou G; Zhu H
    Biochem Biophys Res Commun; 2020 Sep; 529(4):970-976. PubMed ID: 32819607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
    Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
    Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines.
    Wang W; Liu P; Lavrijsen M; Li S; Zhang R; Li S; van de Geer WS; van de Werken HJG; Peppelenbosch MP; Smits R
    Sci Rep; 2021 Apr; 11(1):7470. PubMed ID: 33811251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The binding mechanism of a novel nicotinamide isostere inhibiting with TNKSs: a molecular dynamic simulation and binding free energy calculation.
    Feng TT; Zhang YJ; Chen H; Fan S; Han JG
    J Biomol Struct Dyn; 2016; 34(3):517-28. PubMed ID: 25933061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XAV939, a Wnt/β-catenin pathway modulator, has inhibitory effects on LPS-induced inflammatory response.
    Jang J; Jung Y; Chae S; Bae T; Kim SM; Shim YJ; Chung SI; Yoon Y
    Immunopharmacol Immunotoxicol; 2019 Jun; 41(3):394-402. PubMed ID: 30466341
    [No Abstract]   [Full Text] [Related]  

  • 36. XAV939 Inhibits Intima Formation by Decreasing Vascular Smooth Muscle Cell Proliferation and Migration Through Blocking Wnt Signaling.
    Chen L; Zhuang J; Singh S; Wang K; Xiong M; Xu D; Chen W; Pang J; Xu Y; Li X
    J Cardiovasc Pharmacol; 2016 Dec; 68(6):414-424. PubMed ID: 27525574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft.
    Martins-Neves SR; Paiva-Oliveira DI; Fontes-Ribeiro C; Bovée JVMG; Cleton-Jansen AM; Gomes CMF
    Cancer Lett; 2018 Feb; 414():1-15. PubMed ID: 29126913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
    Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tankyrase is necessary for canonical Wnt signaling during kidney development.
    Karner CM; Merkel CE; Dodge M; Ma Z; Lu J; Chen C; Lum L; Carroll TJ
    Dev Dyn; 2010 Jul; 239(7):2014-23. PubMed ID: 20549720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II.
    Leenders RGG; Brinch SA; Sowa ST; Amundsen-Isaksen E; Galera-Prat A; Murthy S; Aertssen S; Smits JN; Nieczypor P; Damen E; Wegert A; Nazaré M; Lehtiö L; Waaler J; Krauss S
    J Med Chem; 2021 Dec; 64(24):17936-17949. PubMed ID: 34878777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.